Skip to main content
Equibles

Man Group plc

Position in ANIK — Anika Therapeutics, Inc.

CIK 1637460 LONDON, X0
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,058,616
+$256,368 QoQ
Shares Held
140,712
+13.2% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 134 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Man Group plc holds $452,779,482 across 30 Drug Manufacturers - Specialty & Generic names. ANIK ranks #19 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,805,003 $129,707,515
2 NBIX
Neurocrine Biosciences Inc
 601,019 $101,295,742
3 UTHR
UNITED THERAPEUTICS Corp
 134,890 $73,087,447
4 VTRS
Viatris Inc
 3,523,052 $55,946,065
5 PRGO
PERRIGO Co plc
 1,530,206 $15,898,840
6 BCRX
Biocryst Pharmaceuticals Inc
 732,867 $7,328,670
7 SUPN
Supernus Pharmaceuticals, Inc.
 156,422 $7,275,186
8 BHC
Bausch Health Companies Inc.
 1,451,781 $7,157,279

All Filings in ANIK

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,058,616 140,712
2026-03-31 $1,802,248 124,293
2025-12-31 $617,711 64,278
2025-09-30 $138,913 14,778
2025-06-30 $140,375 13,268
2023-12-31 $673,002 29,700
2023-09-30 $495,558 26,600
2023-06-30 $667,686 25,700
2023-03-31 $327,408 11,400
2022-12-31 $355,200 12,000